Any Currency facing loss of Cross Country victory

Any Currency (noseband,right) and Aidan Coleman

Any Currency was a popular winner at the Cheltenham Festival

  PICTURE: Patrick McCann (racingpost.com.photos)  

 By Lee Mottershead 8:32AM 7 JUN 2016 

VETERAN chaser Any Currency is set to be stripped of his popular Cheltenham Festival success in this year’s Glenfarclas Cross-Country Chase after a prohibited substance was found in a sample taken following that victory.

The Racing Post understands the BHA will today announce a disciplinary panel hearing is to take place in the near future that seems likely to trigger the disqualification of the 13-year-old, who gave local trainer Martin Keighley his first win at jumping’s biggest meeting.

Cortisone substance triamcinolone acetonide, which can legitimately be used to treat horses in training but must not be present in their system on racedays, was found in Any Currency, who had finished second in the previous two runnings of Britain’s biggest cross-country chase.

Any Currency’s Cash Is King syndicate owners are known to be unhappy about the likely disqualification, in part because it is thought the horse was administered with the cortisone medication 42 days before he won the Cheltenham race under Aidan Coleman on March 16.

The BHA introduced a new rule last year requiring a mandatory 14-day stand-down period from racing for horses who have been given any intra-articular corticosteroid (cortisone injection).

Although Keighley could be fined anything between £750 and £10,000 it is believed the BHA is not alleging the trainer is guilty of any intentional wrongdoing.

If Any Currency is disqualified the promoted winner would be the Enda Bolger-trained Josies Orders, who was ridden by Nina Carberry.

 
Horse Racing News | Racing Post

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close